An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network
NCT04564079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-02-04
Summary
A Multi-centre Observational Study to Evaluate the Clinical Utility of Returning Genomic Aberration results Using the Oncomine Precision Assay in Advanced or Metastatic Non-Small Cell Lung Cancer Patients within the Exactis Network
Conditions
Sponsors & Collaborators
-
Exactis Innovation
lead OTHER
Principal Investigators
-
Jason Agulnik, MD · Principal Investigator
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2023-07-18
- Completion
- 2023-11-21
Countries
- Canada
Study Locations
More Related Trials
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
NCT06842056 ·Status: NOT_YET_RECRUITING
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
NCT04968548 ·Status: ACTIVE_NOT_RECRUITING
-
A Study in Non-Small Cell Lung Cancer
NCT07174388 ·Status: RECRUITING
-
Breath Analysis to Diagnose Lung Cancer
NCT03250390 ·Status: COMPLETED ·Phase: NA
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients
NCT04548960 ·Status: UNKNOWN ·Phase: NA
-
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
NCT01414595 ·Status: COMPLETED
-
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers
NCT01647867 ·Status: COMPLETED ·Phase: NA
-
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer
NCT04939324 ·Status: UNKNOWN ·Phase: NA
-
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
NCT03499678 ·Status: TERMINATED
-
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00450281 ·Status: COMPLETED
-
NSCLC Liquid Biopsies and Exhaled VOC
NCT06707519 ·Status: RECRUITING
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
NCT03791034 ·Status: RECRUITING
-
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
NCT05794529 ·Status: RECRUITING
-
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
NCT04712877 ·Status: RECRUITING
-
NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"
NCT03771404 ·Status: UNKNOWN ·Phase: NA
-
Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer
NCT06341387 ·Status: RECRUITING
-
Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy
NCT06974097 ·Status: NOT_YET_RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN